BioLargo, Inc. (BLGO)
OTCMKTS
· Delayed Price · Currency is USD
0.2300
-0.0020 (-0.86%)
Apr 17, 2025, 4:00 PM EDT
BioLargo Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.55 | 3.54 | 1.85 | 0.96 | 0.72 | Upgrade
|
| Cash & Short-Term Investments | 3.55 | 3.54 | 1.85 | 0.96 | 0.72 | Upgrade
|
| Cash Growth | 0.25% | 91.19% | 92.41% | 34.36% | 9.31% | Upgrade
|
| Receivables | 3.17 | 2.61 | 1.06 | 0.51 | 0.48 | Upgrade
|
| Inventory | 0.33 | 0.15 | 0.12 | 0.24 | 0.28 | Upgrade
|
| Prepaid Expenses | 0.09 | 0.06 | 0.12 | 0.09 | 0.03 | Upgrade
|
| Total Current Assets | 7.14 | 6.36 | 3.15 | 1.8 | 1.51 | Upgrade
|
| Property, Plant & Equipment | 3.19 | 1.75 | 1.15 | 0.51 | 0.4 | Upgrade
|
| Long-Term Investments | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 2.15 | Upgrade
|
| Other Long-Term Assets | 0.18 | 0.07 | 0.52 | 0.66 | 0.82 | Upgrade
|
| Total Assets | 10.51 | 8.21 | 4.86 | 3.02 | 4.94 | Upgrade
|
| Accounts Payable | 1.07 | 1.35 | 0.9 | 0.5 | 0.72 | Upgrade
|
| Accrued Expenses | 0.15 | 0.3 | 0.28 | 0.29 | 0.33 | Upgrade
|
| Current Portion of Long-Term Debt | 0.55 | 0.3 | 0.1 | 0.31 | 2.33 | Upgrade
|
| Current Portion of Leases | 0.19 | 0.11 | 0.1 | 0.1 | 0.11 | Upgrade
|
| Current Unearned Revenue | - | 0.3 | 0.02 | 0.09 | 0.05 | Upgrade
|
| Other Current Liabilities | 0.68 | 0.36 | 0.18 | 0.08 | - | Upgrade
|
| Total Current Liabilities | 2.65 | 2.71 | 1.58 | 1.37 | 3.54 | Upgrade
|
| Long-Term Debt | 0.53 | 0.29 | 0.5 | 0.37 | 0.51 | Upgrade
|
| Long-Term Leases | 1.28 | 1 | 0.77 | 0.35 | 0.23 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.9 | Upgrade
|
| Total Liabilities | 4.46 | 4 | 2.85 | 2.09 | 5.18 | Upgrade
|
| Common Stock | 0.2 | 0.2 | 0.19 | 0.17 | 0.15 | Upgrade
|
| Additional Paid-In Capital | 158.33 | 154.02 | 148.44 | 143.72 | 135.85 | Upgrade
|
| Retained Earnings | -149.5 | -147.1 | -143.59 | -139.12 | -132.04 | Upgrade
|
| Comprehensive Income & Other | -0.18 | -0.28 | -0.15 | -0.12 | -0.1 | Upgrade
|
| Total Common Equity | 8.85 | 6.84 | 4.88 | 4.65 | 3.86 | Upgrade
|
| Minority Interest | -2.8 | -2.64 | -2.87 | -3.72 | -4.09 | Upgrade
|
| Shareholders' Equity | 6.06 | 4.2 | 2.01 | 0.93 | -0.24 | Upgrade
|
| Total Liabilities & Equity | 10.51 | 8.21 | 4.86 | 3.02 | 4.94 | Upgrade
|
| Total Debt | 2.55 | 1.7 | 1.47 | 1.13 | 3.18 | Upgrade
|
| Net Cash (Debt) | 0.99 | 1.84 | 0.38 | -0.17 | -2.46 | Upgrade
|
| Net Cash Growth | -46.01% | 380.68% | - | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.01 | 0.00 | -0.00 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 301.3 | 295.55 | 283.19 | 262.72 | 238.78 | Upgrade
|
| Total Common Shares Outstanding | 301.27 | 292.95 | 278.46 | 255.89 | 225.89 | Upgrade
|
| Working Capital | 4.49 | 3.65 | 1.58 | 0.43 | -2.04 | Upgrade
|
| Book Value Per Share | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Tangible Book Value | 8.85 | 6.84 | 4.88 | 4.65 | 3.86 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.